| Year |
Citation |
Score |
| 2024 |
Tamura R, Yamanobe Y, Fujioka M, Morimoto Y, Fukumura M, Nakaya M, Oishi Y, Sato M, Ueda R, Fujiwara H, Hikichi T, Noji S, Oishi N, Ozawa H, Ogawa K, ... ... Toda M, et al. Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2302376. PMID 38776485 DOI: 10.1200/JCO.23.02376 |
0.395 |
|
| 2022 |
Morimoto Y, Tokumitsu A, Sone T, Hirota Y, Tamura R, Sakamoto A, Nakajima K, Toda M, Kawakami Y, Okano H, Ohta S. TPT1 Supports Proliferation of Neural Stem/Progenitor Cells and Brain Tumor Initiating Cells Regulated by Macrophage Migration Inhibitory Factor (MIF). Neurochemical Research. PMID 35622214 DOI: 10.1007/s11064-022-03629-6 |
0.508 |
|
| 2020 |
Tamura R, Morimoto Y, Sato M, Hikichi T, Yoshida K, Toda M. A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma. Vaccines. 8. PMID 32887369 DOI: 10.3390/vaccines8030498 |
0.315 |
|
| 2020 |
Tamura R, Fujioka M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Sato M, Ueda R, Fujiwara H, Hikichi T, Noji S, Oishi N, Ogawa K, Kawakami Y, Ohira T, ... ... Toda M, et al. Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nature Communications. 11: 2028. PMID 32317644 DOI: 10.1038/S41467-020-16007-Z |
0.45 |
|
| 2020 |
Tamura R, Morimoto Y, Kosugi K, Sato M, Oishi Y, Ueda R, Kikuchi R, Nagashima H, Hikichi T, Noji S, Kawakami Y, Sasaki H, Yoshida K, Toda M. Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series. Bmc Cancer. 20: 301. PMID 32290821 DOI: 10.1186/s12885-020-06783-8 |
0.454 |
|
| 2020 |
Tamura R, Morimoto Y, Kosugi K, Sato M, Oishi Y, Ueda R, Kikuchi R, Nagashima H, Noji S, Kawakami Y, Sasaki H, Yoshida K, Toda M. Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series. Bmc Cancer. 20: 196. PMID 32164575 DOI: 10.1186/s12885-020-6589-x |
0.541 |
|
| 2020 |
Kamamoto D, Kanazawa T, Ishihara E, Yanagisawa K, Tomita H, Ueda R, Jinzaki M, Yoshida K, Toda M. Efficacy of a topical gelatin-thrombin hemostatic matrix, FLOSEAL, in intracranial tumor resection. Surgical Neurology International. 11: 16. PMID 32123604 DOI: 10.25259/SNI_272_2019 |
0.349 |
|
| 2020 |
Tamura R, Sato M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Kuranari Y, Murase M, Yoshida K, Toda M. Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors. Experimental and Molecular Pathology. 114: 104408. PMID 32088190 DOI: 10.1016/j.yexmp.2020.104408 |
0.403 |
|
| 2020 |
Tamura R, Miyoshi H, Morimoto Y, Oishi Y, Sampetrean O, Iwasawa C, Mine Y, Saya H, Yoshida K, Okano H, Toda M. Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect. Human Gene Therapy. PMID 32075424 DOI: 10.1089/Hum.2019.326 |
0.396 |
|
| 2020 |
Tamura R, Morimoto Y, Sato M, Kuranari Y, Oishi Y, Kosugi K, Yoshida K, Toda M. Difference in the hypoxic immunosuppressive microenvironment of patients with neurofibromatosis type 2 schwannomas and sporadic schwannomas. Journal of Neuro-Oncology. PMID 31897926 DOI: 10.1007/s11060-019-03388-5 |
0.365 |
|
| 2019 |
Tamura R, Fujioka M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Sato M, Ueda R, Fujiwara H, Noji S, Oishi N, Ogawa K, Kawakami Y, Ohira T, Yoshida K, ... Toda M, et al. A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nature Communications. 10: 5758. PMID 31848332 DOI: 10.1038/S41467-019-13640-1 |
0.525 |
|
| 2019 |
Tamura R, Miyoshi H, Yoshida K, Okano H, Toda M. Recent progress in the research of suicide gene therapy for malignant glioma. Neurosurgical Review. PMID 31781985 DOI: 10.1007/S10143-019-01203-3 |
0.359 |
|
| 2019 |
Ishihara E, Takahashi S, Fukaya R, Ohta S, Yoshida K, Toda M. Identification of KLRC2 as a candidate marker for brain tumor-initiating cells. Neurological Research. 1-7. PMID 31556357 DOI: 10.1080/01616412.2019.1672390 |
0.427 |
|
| 2019 |
Morimoto Y, Tamura R, Ohara K, Kosugi K, Oishi Y, Kuranari Y, Yoshida K, Toda M. Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma. Journal of Neuro-Oncology. PMID 31240525 DOI: 10.1007/s11060-019-03221-z |
0.347 |
|
| 2019 |
Kosugi K, Tamura R, Ohara K, Morimoto Y, Kuranari Y, Oishi Y, Yoshida K, Toda M. Immunological and vascular characteristics in cavernous sinus meningioma. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 31213381 DOI: 10.1016/j.jocn.2019.06.003 |
0.304 |
|
| 2019 |
Sato M, Tamura R, Tamura H, Mase T, Kosugi K, Morimoto Y, Yoshida K, Toda M. Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors. Journal of Clinical Medicine. 8. PMID 31100921 DOI: 10.3390/jcm8050695 |
0.38 |
|
| 2019 |
Tamura R, Miyoshi H, Sampetrean O, Shinozaki M, Morimoto Y, Iwasawa C, Fukaya R, Mine Y, Masuda H, Maruyama T, Narita M, Saya H, Yoshida K, Okano H, Toda M. Visualization of spatiotemporal dynamics of human glioma stem cell invasion. Molecular Brain. 12: 45. PMID 31060588 DOI: 10.1186/S13041-019-0462-3 |
0.333 |
|
| 2019 |
Tamura R, Ohara K, Morimoto Y, Kosugi K, Oishi Y, Sato M, Yoshida K, Toda M. PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion. Endocrine Pathology. PMID 30903445 DOI: 10.1007/s12022-019-9573-8 |
0.302 |
|
| 2019 |
Kikuchi R, Ueda R, Saito K, Shibao S, Nagashima H, Tamura R, Morimoto Y, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma. Journal of Clinical Medicine. 8. PMID 30791546 DOI: 10.3390/jcm8020263 |
0.511 |
|
| 2019 |
Iwasawa C, Tamura R, Sugiura Y, Suzuki S, Kuzumaki N, Narita M, Suematsu M, Nakamura M, Yoshida K, Toda M, Okano H, Miyoshi H. Increased Cytotoxicity of Herpes Simplex Virus Thymidine Kinase Expression in Human Induced Pluripotent Stem Cells. International Journal of Molecular Sciences. 20. PMID 30769780 DOI: 10.3390/Ijms20040810 |
0.337 |
|
| 2019 |
Sutiono AB, Sidabutar R, Pareira ES, Toda M, Yoshida K. Characteristics intracranial epidermoid cyst between two hospital from developed vs developing institution and literature review Interdisciplinary Neurosurgery. 18: 100500. DOI: 10.1016/J.INAT.2019.100500 |
0.312 |
|
| 2018 |
Kuga D, Toda M, Ozawa H, Ogawa K, Yoshida K. Endoscopic endonasal approach combined with a simultaneous transcranial approach for giant pituitary tumors. World Neurosurgery. PMID 30336293 DOI: 10.1016/j.wneu.2018.10.047 |
0.324 |
|
| 2018 |
Kuga D, Toda M, Yoshida K. Treatment strategy for tuberculum sellae meningiomas based on a preoperative radiological assessment. World Neurosurgery. PMID 30240863 DOI: 10.1016/j.wneu.2018.09.054 |
0.339 |
|
| 2018 |
Tamura R, Ohara K, Sasaki H, Morimoto Y, Kosugi K, Yoshida K, Toda M. Difference in immunosuppressive cells between the peritumoral area and tumor core in glioblastoma. World Neurosurgery. PMID 30165233 DOI: 10.1016/j.wneu.2018.08.133 |
0.364 |
|
| 2018 |
Yoshida K, Toda M, Akiyama T, Takahashi S, Nishimoto M, Ozawa H, Ikari Y, Yoshida K. Combined endoscopic endonasal and video-microscopic transcranial approach with preoperative embolization for a posterior pituitary tumor. World Neurosurgery. PMID 30092469 DOI: 10.1016/j.wneu.2018.07.245 |
0.335 |
|
| 2018 |
Shibao S, Ueda R, Saito K, Kikuchi R, Nagashima H, Kojima A, Kagami H, Pareira ES, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma. Oncotarget. 9: 21569-21579. PMID 29765561 DOI: 10.18632/oncotarget.25131 |
0.506 |
|
| 2018 |
Tamura R, Tomio R, Mohammad F, Toda M, Yoshida K. Analysis of various tracts of mastoid air cells related to CSF leak after the anterior transpetrosal approach. Journal of Neurosurgery. 1-8. PMID 29547085 DOI: 10.3171/2017.9.JNS171622 |
0.301 |
|
| 2017 |
Kikuchi R, Sampetrean O, Saya H, Yoshida K, Toda M. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells. Journal of Neuro-Oncology. PMID 28555424 DOI: 10.1007/s11060-017-2457-1 |
0.455 |
|
| 2017 |
Saito K, Ohta S, Kawakami Y, Yoshida K, Toda M. Functional analysis of KIF20A, a potential immunotherapeutic target for glioma. Journal of Neuro-Oncology. PMID 28070829 DOI: 10.1007/s11060-016-2360-1 |
0.583 |
|
| 2016 |
Toda M. [Pre- and Intra-Operative Supporting Technology for Brain Tumors(1)Endoscopic Endonasal Surgery for Sellar and Clival Lesions]. No Shinkei Geka. Neurological Surgery. 44: 975-987. PMID 27832622 DOI: 10.11477/mf.1436203412 |
0.302 |
|
| 2016 |
Fukaya R, Ohta S, Yaguchi T, Matsuzaki Y, Sugihara E, Okano H, Saya H, Kawakami Y, Kawase T, Yoshida K, Toda M. MIF maintains the tumorigenic capacity of brain tumor-initiating cells by directly inhibiting p53. Cancer Research. PMID 26980763 DOI: 10.1158/0008-5472.Can-15-1011 |
0.573 |
|
| 2016 |
Tanaka S, Sasaki H, Ohara K, Kono M, Mizutani K, Kitamura Y, Kanai R, Akiyama T, Toda M, Kohno M, Yoshida K. Mpth-08. Molecular Investigation Of Brain Tumors Progressing During Pregnancy Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.446 |
0.311 |
|
| 2016 |
Tamura R, Toda M, Kohno M, Ozawa H, Tomita T, Akiyama T, Ogawa K, Yoshida K. Endonasal endoscopic approach for a giant cavernous sinus meningioma that extended to the middle cranial fossa with preoperative embolization Interdisciplinary Neurosurgery: Advanced Techniques and Case Management. 6: 20-22. DOI: 10.1016/j.inat.2016.05.006 |
0.321 |
|
| 2015 |
Shibao S, Toda M, Yoshida K. Giant cell tumors of the clivus: Case report and literature review. Surgical Neurology International. 6: S623-7. PMID 26682086 DOI: 10.4103/2152-7806.170459 |
0.336 |
|
| 2015 |
Sasaki H, Hirose Y, Yazaki T, Kitamura Y, Katayama M, Kimura T, Fujiwara H, Toda M, Ohira T, Yoshida K. Upfront chemotherapy and subsequent resection for molecularly defined gliomas. Journal of Neuro-Oncology. PMID 26007163 DOI: 10.1007/S11060-015-1817-Y |
0.334 |
|
| 2015 |
Kikuchi R, Toda M, Sampetrean O, Saya H, Yoshida K. CBIO-17EXPRESSION AND FUNCTIONAL ANALYSIS OF AN ONCOANTIGEN, DEPDC1, IN MALIGNANT GLIOMA Neuro-Oncology. 17: v58.3-v58. DOI: 10.1093/neuonc/nov209.17 |
0.426 |
|
| 2014 |
Saito K, Iizuka Y, Ohta S, Takahashi S, Nakamura K, Saya H, Yoshida K, Kawakami Y, Toda M. Functional analysis of a novel glioma antigen, EFTUD1. Neuro-Oncology. 16: 1618-29. PMID 25015090 DOI: 10.1093/neuonc/nou132 |
0.687 |
|
| 2014 |
Sasaki H, Hirose Y, Yazaki T, Kimura T, Fujiwara H, Kitamura Y, Katayama M, Toda M, Ohira T, Yoshida K. MOLECULAR-GUIDED NEOADJUVANT APPROACH FOR CHEMOSENSITIVE GLIOMAS Neuro-Oncology. 16: iii50-iii50. DOI: 10.1093/Neuonc/Nou209.32 |
0.351 |
|
| 2014 |
Borghei-Razavi H, Tomio R, Toda M, Schick U, Kawase T, Yoshida K. Tumor-Induced Surgical Anatomical Variations of Cranial Nerves in Anterior Petrosectomy for Petroclival Tumors Journal of Neurological Surgery Part B: Skull Base. 75. DOI: 10.1055/s-0034-1384069 |
0.33 |
|
| 2013 |
Ohta S, Misawa A, Lefebvre V, Okano H, Kawakami Y, Toda M. Sox6 up-regulation by macrophage migration inhibitory factor promotes survival and maintenance of mouse neural stem/progenitor cells. Plos One. 8: e74315. PMID 24066135 DOI: 10.1371/Journal.Pone.0074315 |
0.53 |
|
| 2013 |
Toda M. Glioma stem cells and immunotherapy for the treatment of malignant gliomas. Isrn Oncology. 2013: 673793. PMID 23762610 DOI: 10.1155/2013/673793 |
0.345 |
|
| 2013 |
Sano K, Toda M, Sasaki H, Kitamura Y, Mikami S, Hirato J, Inoue S, Kawase T, Yoshida K. Infratentorial low-grade oligoastrocytoma with aggressive clinical behavior in an adult: a case report with genetic characterization. Brain Tumor Pathology. 30: 99-103. PMID 22752622 DOI: 10.1007/s10014-012-0111-3 |
0.313 |
|
| 2012 |
Ohta S, Misawa A, Fukaya R, Inoue S, Kanemura Y, Okano H, Kawakami Y, Toda M. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells. Journal of Cell Science. 125: 3210-20. PMID 22454509 DOI: 10.1242/Dev.088658 |
0.545 |
|
| 2012 |
Saito K, Toda M, Tomita T, Ogawa K, Yoshida K. Surgical results of an endoscopic endonasal approach for clival chordomas. Acta Neurochirurgica. 154: 879-86. PMID 22402876 DOI: 10.1007/s00701-012-1317-1 |
0.315 |
|
| 2012 |
Takahashi S, Fusaki N, Ohta S, Iwahori Y, Iizuka Y, Inagawa K, Kawakami Y, Yoshida K, Toda M. Downregulation of KIF23 suppresses glioma proliferation. Journal of Neuro-Oncology. 106: 519-29. PMID 21904957 DOI: 10.1007/s11060-011-0706-2 |
0.72 |
|
| 2012 |
Saga I, Toda M. Brain Tumor Stem Cells and Immunotherapy Journal of Cancer Research Updates. 1. DOI: 10.6000/1929-2279.2012.01.01.06 |
0.395 |
|
| 2011 |
Tabuse M, Ohta S, Ohashi Y, Fukaya R, Misawa A, Yoshida K, Kawase T, Saya H, Thirant C, Chneiweiss H, Matsuzaki Y, Okano H, Kawakami Y, Toda M. Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells. Molecular Cancer. 10: 60. PMID 21600039 DOI: 10.1186/1476-4598-10-60 |
0.664 |
|
| 2011 |
Takahashi S, Yamada-Okabe H, Hamada K, Ohta S, Kawase T, Yoshida K, Toda M. Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells. Journal of Neuro-Oncology. 103: 267-76. PMID 20845060 DOI: 10.1007/s11060-010-0398-z |
0.407 |
|
| 2011 |
Ohkusu-Tsukada K, Ohta S, Kawakami Y, Toda M. Adjuvant effects of formalin-inactivated HSV through activation of dendritic cells and inactivation of myeloid-derived suppressor cells in cancer immunotherapy. International Journal of Cancer. Journal International Du Cancer. 128: 119-31. PMID 20232389 DOI: 10.1002/ijc.25319 |
0.527 |
|
| 2010 |
Ohkusu-Tsukada K, Toda M, Udono H, Kawakami Y, Takahashi K. Targeted inhibition of IL-10-secreting CD25- Treg via p38 MAPK suppression in cancer immunotherapy. European Journal of Immunology. 40: 1011-21. PMID 20127675 DOI: 10.1002/eji.200939513 |
0.475 |
|
| 2010 |
Fukaya R, Ohta S, Yamaguchi M, Fujii H, Kawakami Y, Kawase T, Toda M. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Letters. 291: 150-7. PMID 19913993 DOI: 10.1016/j.canlet.2009.10.010 |
0.565 |
|
| 2010 |
Ueda R, Ohkusu-Tsukada K, Fusaki N, Soeda A, Kawase T, Kawakami Y, Toda M. Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy. International Journal of Cancer. Journal International Du Cancer. 126: 919-29. PMID 19728337 DOI: 10.1002/ijc.24851 |
0.537 |
|
| 2010 |
Toda M. Immunotherapy targeted at brain cancer stem cells Open Cancer Immunology Journal. 3: 48-50. DOI: 10.2174/1876401001003010048 |
0.382 |
|
| 2010 |
Ohta S, Kawakami Y, Okano H, Toda M. Functional analysis of macrophage migration inhibitory factor (MIF) in the mouse neural stem/progenitor cells Neuroscience Research. 68: e245-e246. DOI: 10.1016/J.Neures.2010.07.1088 |
0.495 |
|
| 2010 |
Ohta S, Kawakami Y, Okano H, Toda M. P45. Functional analysis of macrophage migration inhibitory factor (MIF) in the mouse neural stem/progenitor cells Differentiation. 80: S32. DOI: 10.1016/J.Diff.2010.09.051 |
0.528 |
|
| 2009 |
Hayashi K, Ohta S, Kawakami Y, Toda M. Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF. Neuroscience Research. 64: 96-103. PMID 19428687 DOI: 10.1016/j.neures.2009.01.018 |
0.49 |
|
| 2009 |
Ohta S, Kawakami Y, Okano H, Kawase T, Toda M. Macrophage migration inhibitory factor (MIF) promotes proliferation and cell survival of neural stem/progenitor cells Neuroscience Research. 65: S91. DOI: 10.1016/J.Neures.2009.09.375 |
0.51 |
|
| 2008 |
Toda M. Intraoperative navigation and fluorescence imagings in malignant glioma surgery. The Keio Journal of Medicine. 57: 155-61. PMID 18854668 DOI: 10.2302/kjm.57.155 |
0.352 |
|
| 2008 |
Yaguchi M, Ohta S, Toyama Y, Kawakami Y, Toda M. Functional recovery after spinal cord injury in mice through activation of microglia and dendritic cells after IL-12 administration. Journal of Neuroscience Research. 86: 1972-80. PMID 18438913 DOI: 10.1002/jnr.21658 |
0.475 |
|
| 2008 |
Ueda R, Kinoshita E, Ito R, Kawase T, Kawakami Y, Toda M. Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6. International Journal of Cancer. Journal International Du Cancer. 122: 2274-9. PMID 18224680 DOI: 10.1002/ijc.23366 |
0.528 |
|
| 2008 |
Ohta S, Ueda Y, Yaguchi M, Matsuzaki Y, Nakamura M, Toyama Y, Tanioka Y, Tamaoki N, Nomura T, Okano H, Kawakami Y, Toda M. Isolation and characterization of dendritic cells from common marmosets for preclinical cell therapy studies. Immunology. 123: 566-74. PMID 18005037 DOI: 10.1111/J.1365-2567.2007.02727.X |
0.518 |
|
| 2008 |
Toda M. Analysis of dendritic cells from common marmosets for the treatment of CNS injury Inflammation and Regeneration. 28: 174-180. DOI: 10.2492/Inflammregen.28.174 |
0.338 |
|
| 2007 |
Hattori Y, Ohta S, Hamada K, Yamada-Okabe H, Kanemura Y, Matsuzaki Y, Okano H, Kawakami Y, Toda M. Identification of a neuron-specific human gene, KIAA1110, that is a guanine nucleotide exchange factor for ARF1. Biochemical and Biophysical Research Communications. 364: 737-42. PMID 17981261 DOI: 10.1016/J.Bbrc.2007.10.041 |
0.52 |
|
| 2007 |
Ueda R, Yoshida K, Kawase T, Kawakami Y, Toda M. Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients. International Journal of Cancer. Journal International Du Cancer. 120: 1704-11. PMID 17230535 DOI: 10.1002/ijc.22472 |
0.531 |
|
| 2007 |
Ohta S, Okano H, Kawase T, Toda M. Sox6 is expressed in mouse embryonic neural stem/progenitor cells (NSPCs) and contributes to their maintenance and/or survival Neuroscience Research. 58: S199. DOI: 10.1016/J.Neures.2007.06.896 |
0.316 |
|
| 2006 |
Udagawa M, Kudo-Saito C, Hasegawa G, Yano K, Yamamoto A, Yaguchi M, Toda M, Azuma I, Iwai T, Kawakami Y. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 7465-75. PMID 17189420 DOI: 10.1158/1078-0432.CCR-06-1840 |
0.573 |
|
| 2006 |
Iizuka Y, Kojima H, Kobata T, Kawase T, Kawakami Y, Toda M. Identification of a glioma antigen, GARC-1, using cytotoxic T lymphocytes induced by HSV cancer vaccine. International Journal of Cancer. Journal International Du Cancer. 118: 942-9. PMID 16152596 DOI: 10.1002/ijc.21432 |
0.699 |
|
| 2005 |
Matsushita H, Uenaka A, Ono T, Hasegawa K, Sato S, Koizumi F, Nakagawa K, Toda M, Shingo T, Ichikawa T, Noguchi Y, Tamiya T, Furuta T, Kawase T, Date I, et al. Identification of glioma-specific RFX4-E and -F isoforms and humoral immune response in patients. Cancer Science. 96: 801-9. PMID 16271074 DOI: 10.1111/j.1349-7006.2005.00112.x |
0.341 |
|
| 2004 |
Ueda R, Yoshida K, Kawakami Y, Kawase T, Toda M. Immunohistochemical analysis of SOX6 expression in human brain tumors. Brain Tumor Pathology. 21: 117-20. PMID 15696972 DOI: 10.1007/BF02482186 |
0.593 |
|
| 2004 |
Ueda R, Yoshida K, Kawakami Y, Kawase T, Toda M. Expression of a transcriptional factor, SOX6, in human gliomas. Brain Tumor Pathology. 21: 35-8. PMID 15696967 DOI: 10.1007/BF02482175 |
0.559 |
|
| 2004 |
Kawakami Y, Fujita T, Matsuzaki Y, Sakurai T, Tsukamoto M, Toda M, Sumimoto H. Identification of human tumor antigens and its implications for diagnosis and treatment of cancer. Cancer Science. 95: 784-91. PMID 15504244 DOI: 10.1111/j.1349-7006.2004.tb02182.x |
0.573 |
|
| 2004 |
Ohashi Y, Ueda M, Kawase T, Kawakami Y, Toda M. Identification of an epigenetically silenced gene, RFX1, in human glioma cells using restriction landmark genomic scanning. Oncogene. 23: 7772-9. PMID 15334059 DOI: 10.1038/sj.onc.1208058 |
0.618 |
|
| 2004 |
Mikami Y, Okano H, Sakaguchi M, Nakamura M, Shimazaki T, Okano HJ, Kawakami Y, Toyama Y, Toda M. Implantation of dendritic cells in injured adult spinal cord results in activation of endogenous neural stem/progenitor cells leading to de novo neurogenesis and functional recovery. Journal of Neuroscience Research. 76: 453-65. PMID 15114617 DOI: 10.1002/Jnr.20086 |
0.49 |
|
| 2004 |
Iizuka Y, Suzuki A, Kawakami Y, Toda M. Augmentation of antitumor immune responses by multiple intratumoral inoculations of replication-conditional HSV and interleukin-12. Journal of Immunotherapy (Hagerstown, Md. : 1997). 27: 92-8. PMID 14770080 DOI: 10.1097/00002371-200403000-00002 |
0.687 |
|
| 2004 |
Ueda R, Iizuka Y, Yoshida K, Kawase T, Kawakami Y, Toda M. Identification of a human glioma antigen, SOX6, recognized by patients' sera. Oncogene. 23: 1420-7. PMID 14691456 DOI: 10.1038/sj.onc.1207252 |
0.693 |
|
| 2003 |
Toda M. Immuno-viral therapy as a new approach for the treatment of brain tumors. Drug News & Perspectives. 16: 223-9. PMID 12942152 DOI: 10.1358/dnp.2003.16.4.829334 |
0.413 |
|
| 2002 |
Mikami Y, Toda M, Watanabe M, Nakamura M, Toyama Y, Kawakami Y. A simple and reliable behavioral analysis of locomotor function after spinal cord injury in mice. Technical note. Journal of Neurosurgery. 97: 142-7. PMID 12120639 DOI: 10.3171/Spi.2002.97.1.0142 |
0.445 |
|
| 2002 |
Toda M, Iizuka Y, Kawase T, Uyemura K, Kawakami Y. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV. Cancer Gene Therapy. 9: 356-64. PMID 11960286 DOI: 10.1038/sj.cgt.7700446 |
0.786 |
|
| 2002 |
Endo T, Toda M, Watanabe M, Iizuka Y, Kubota T, Kitajima M, Kawakami Y. In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer. Cancer Gene Therapy. 9: 142-8. PMID 11857031 DOI: 10.1038/sj.cgt.7700407 |
0.676 |
|
| 2002 |
Toda M, Okano H. Neural stem cell and regeneration of central nervous system Ensho Saisei. 22: 469-473. DOI: 10.2492/Jsir.22.469 |
0.312 |
|
| 2001 |
Ishii K, Toda M, Nakai Y, Asou H, Watanabe M, Nakamura M, Yato Y, Fujimura Y, Kawakami Y, Toyama Y, Uyemura K. Increase of oligodendrocyte progenitor cells after spinal cord injury. Journal of Neuroscience Research. 65: 500-7. PMID 11550218 DOI: 10.1002/jnr.1180 |
0.692 |
|
| 2001 |
Toda M, Martuza RL, Rabkin SD. Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine. Gene Therapy. 8: 332-9. PMID 11313808 DOI: 10.1038/Sj.Gt.3301392 |
0.541 |
|
| 2001 |
Toda M, Iizuka Y, Yu W, Imai T, Ikeda E, Yoshida K, Kawase T, Kawakami Y, Okano H, Uyemura K. Expression of the neural RNA-binding protein Musashi1 in human gliomas. Glia. 34: 1-7. PMID 11284014 DOI: 10.1002/Glia.1034 |
0.794 |
|
| 2000 |
Toda M, Martuza RL, Rabkin SD. Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 324-9. PMID 11020347 DOI: 10.1006/mthe.2000.0130 |
0.574 |
|
| 1999 |
Hunter WD, Martuza RL, Feigenbaum F, Todo T, Mineta T, Yazaki T, Toda M, Newsome JT, Platenberg RC, Manz HJ, Rabkin SD. Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates. Journal of Virology. 73: 6319-26. PMID 10400723 DOI: 10.1128/Jvi.73.8.6319-6326.1999 |
0.508 |
|
| 1999 |
Toda M, Shirao T, Uyemura K. Suppression of an actin-binding protein, drebrin, by antisense transfection attenuates neurite outgrowth in neuroblastoma B104 cells. Brain Research. Developmental Brain Research. 114: 193-200. PMID 10320758 DOI: 10.1016/S0165-3806(99)00030-9 |
0.673 |
|
| 1999 |
Toda M, Rabkin SD, Kojima H, Martuza RL. Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. Human Gene Therapy. 10: 385-93. PMID 10048391 DOI: 10.1089/10430349950018832 |
0.599 |
|
| 1999 |
Toda M, Miura M, Asou H, Sugiyama I, Kawase T, Uyemura K. Suppression of glial tumor growth by expression of glial fibrillary acidic protein. Neurochemical Research. 24: 339-43. PMID 9972884 DOI: 10.1023/A:1022538810581 |
0.705 |
|
| 1998 |
Toda M, Rabkin SD, Martuza RL. Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. Human Gene Therapy. 9: 2177-85. PMID 9794202 DOI: 10.1089/hum.1998.9.15-2177 |
0.579 |
|
| 1998 |
Toda M, Martuza RL, Kojima H, Rabkin SD. In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity. Journal of Immunology (Baltimore, Md. : 1950). 160: 4457-64. PMID 9574551 |
0.509 |
|
| 1995 |
Asou H, Murakami K, Toda M, Uyemura K. Development of oligodendrocyte and myelination in the central nervous system. The Keio Journal of Medicine. 44: 47-52. PMID 7658645 DOI: 10.2302/Kjm.44.47 |
0.635 |
|
| 1995 |
Ikeda K, Shirao T, Toda M, Asada H, Toya S, Uyemura K. Effect of a neuron-specific actin-binding protein, drebrin A, on cell-substratum adhesion. Neuroscience Letters. 194: 197-200. PMID 7478237 DOI: 10.1016/0304-3940(95)11760-T |
0.679 |
|
| 1994 |
Toda M, Miura M, Asou H, Toya S, Uyemura K. Cell growth suppression of astrocytoma C6 cells by glial fibrillary acidic protein cDNA transfection. Journal of Neurochemistry. 63: 1975-8. PMID 7931355 DOI: 10.1046/J.1471-4159.1994.63051975.X |
0.694 |
|
| 1994 |
Toda M, Asou H, Miura M, Toya S, Uyemura K. GFAP transfected cells produce laminin, leading to neurite outgrowth promotion. Neuroreport. 5: 1969-72. PMID 7841387 DOI: 10.1097/00001756-199410000-00033 |
0.68 |
|
| 1994 |
Asou H, Takeda Y, Toda M, Miura M, Uyemura K. A functional role for the middle extracellular region of multifunctional L1 protein in neurite fasciculation Neuroscience Research Supplements. 19: S105. DOI: 10.1016/0921-8696(94)92558-5 |
0.614 |
|
| 1994 |
Toda M, Asou H, Miura M, Toya S, Uyemura K. Induction of laminin in GFAP cDNA transfected cells Neuroscience Research Supplements. 19: S95. DOI: 10.1016/0921-8696(94)92529-1 |
0.679 |
|
| 1993 |
Toda M, Shirao T, Minoshima S, Shimizu N, Toya S, Uyemura K. Molecular cloning of cDNA encoding human drebrin E and chromosomal mapping of its gene. Biochemical and Biophysical Research Communications. 196: 468-72. PMID 8216329 DOI: 10.1006/bbrc.1993.2273 |
0.635 |
|
| 1992 |
Kaub P, Shirao T, Takeda Y, Toda M, Uyemura K. Identification and sequence analysis of rat drebrin embryonic isoform by polymerase chain reaction Neuroscience Research Supplements. 17: 178. DOI: 10.1016/0921-8696(92)91008-T |
0.614 |
|
| Show low-probability matches. |